Efficacy of GLI antagonists in triple-negative inflammatory breast cancer 2D and 3D models
Publication
, Conference
Oladapo, H; Ji, X; Shehata, H; Tarpley, M; Chdid, L; Lamson, D; Bao, X; Sauer, S; Devi, GR; Williams, KP
Published in: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
July 1, 2018
Duke Scholars
Published In
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
EISSN
1538-7755
ISSN
1055-9965
Publication Date
July 1, 2018
Volume
27
Issue
7
Start / End Page
131 / 132
Location
Atlanta, GA
Publisher
AMER ASSOC CANCER RESEARCH
Conference Name
10th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
Related Subject Headings
- Epidemiology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Oladapo, H., Ji, X., Shehata, H., Tarpley, M., Chdid, L., Lamson, D., … Williams, K. P. (2018). Efficacy of GLI antagonists in triple-negative inflammatory breast cancer 2D and 3D models. In CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (Vol. 27, pp. 131–132). Atlanta, GA: AMER ASSOC CANCER RESEARCH.
Oladapo, Helen, Xiaojia Ji, Hassan Shehata, Mike Tarpley, Lhoucine Chdid, David Lamson, Xuhui Bao, Scott Sauer, Gayathri R. Devi, and Kevin P. Williams. “Efficacy of GLI antagonists in triple-negative inflammatory breast cancer 2D and 3D models.” In CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 27:131–32. AMER ASSOC CANCER RESEARCH, 2018.
Oladapo H, Ji X, Shehata H, Tarpley M, Chdid L, Lamson D, et al. Efficacy of GLI antagonists in triple-negative inflammatory breast cancer 2D and 3D models. In: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. AMER ASSOC CANCER RESEARCH; 2018. p. 131–2.
Oladapo, Helen, et al. “Efficacy of GLI antagonists in triple-negative inflammatory breast cancer 2D and 3D models.” CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, vol. 27, no. 7, AMER ASSOC CANCER RESEARCH, 2018, pp. 131–32.
Oladapo H, Ji X, Shehata H, Tarpley M, Chdid L, Lamson D, Bao X, Sauer S, Devi GR, Williams KP. Efficacy of GLI antagonists in triple-negative inflammatory breast cancer 2D and 3D models. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. AMER ASSOC CANCER RESEARCH; 2018. p. 131–132.
Published In
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
EISSN
1538-7755
ISSN
1055-9965
Publication Date
July 1, 2018
Volume
27
Issue
7
Start / End Page
131 / 132
Location
Atlanta, GA
Publisher
AMER ASSOC CANCER RESEARCH
Conference Name
10th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
Related Subject Headings
- Epidemiology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences